Is stock market outperformance for biotech still in the cards for 2023?
Chronicling the market’s rise and fall—and signs of potential recovery.
What a changing economy and related trends could mean for 2023.
Perspectives from a board member and an aspiring board member on how to increase the number of qualified women on boards.
Will biopharma investment heat up and signal better fortunes for 2023?
Focus is on cash: who’s got it, who doesn’t, and what will it mean?